期刊文献+

腹腔镜胆囊切除术围术期抗菌药物合理应用干预对照研究 被引量:6

Control Study on Perioperative Rational Application of Antimicrobials in Laparoscopic Cholecystectomy
原文传递
导出
摘要 目的:探讨我院肝胆外科实施围术期抗菌药物合理应用方案的可行性。方法:比较我院肝胆外科腹腔镜胆囊切除术(LC)2009年1-6月92例出院患者(非干预组)和2010年1-6月90例出院患者(干预组)围术期应用抗菌药物的合理性。结果:与非干预组比较,干预组抗菌药物平均预防应用时间、预防用氟喹诺酮类药比例、出院带药率均下降;平均住院时间、手术部位感染率干预组与非干预组比较差异无统计学意义(P>0.05)。结论:我院肝胆外科实施的合理用药方案提高了抗菌药物预防用药的合理性,表明本方案有效、可行。 OBJECTIVE: To evaluate the feasibility of perioperative rational application of antimicrobials in hepatobiliary surgery department of our hospital. METHODS: 92 discharged patients underwent laparoscopic cholecystectomy (LC) in hepatobiliary surgery department of our hospital during Jan.-Jun. in 2009 were as non-intervention group, and 90 discharged patients who were discharged from hospital during Jan.-Jun. in 2010 were as intervention group, the rationality of antimicrobials was compared between two groups. RESULTS: Compared with the non-intervention group, the average application duration of antimicrobials, the proportion of the prophylactic use of fluoroquinolone and the rate of taking medicine at discharge of intervention group all decreased; there was no statistical significance in average hospitalization days and surgical wound infection rate between in intervention group and non-intervention group(P〉0.05). CONCLUSION: The implementation of rational drug use scheme improves the rationality of prophylactic application of antibacterials in our hospital, which indicates the scheme is effective and feasible.
作者 许璕 窦文琴
出处 《中国药房》 CAS CSCD 2012年第2期120-122,共3页 China Pharmacy
关键词 肝胆外科 腹腔镜胆囊切除术 围术期 抗菌药物 合理用药 干预对照研究 Hepatobiliary surgery department Laparoscopic cholecystectomy Perioperative period Antimicrobials Rational drug use Intervention control study
  • 相关文献

参考文献4

二级参考文献24

共引文献285

同被引文献37

  • 1中华人民共和国卫生部.医院感染诊断标准(试行)[S].[S].中华人民共和国卫生部,2001.2.
  • 2吴在德,吴肇汉.外科学[M].6版,北京:人民卫生出版社,2005:836.
  • 3中华人民共和国卫生部,抗菌药物临床应用指导原则,北京:中华人民共和国卫生部.2004,3
  • 4Dongil Choi,Hyo K.Lim.Liver abscess aRcr percutaneous radiofrequency ablation for hepatocellular carcinomas:Frequency and Risk Factors[J].AJR 2005,184:1860-1861.
  • 5Lee JH,Han HS,Min SK, et al.Laparoscopic repair of various types of biliary-enteric fistula:three cases[J].Surg Endosc,2004,18:349.
  • 6蔡武.肝胆外科T管引流并发症原因及护理体会[J].中国健康月刊,2011,30(9):203-204.
  • 7中华人民共和国卫生部.卫生部办公厅关于抗菌药物临床应用管理有关问题的通知.2009-03-23.
  • 8卫生部办公厅.关于印发《第二批单病种质量控制指标》的通知.2010-11-01.
  • 9Judy A. Shea,Jesse A. Berlin,Dale R. Bachwich,Rudolf N. Staroscik,Peter F. Malet,Maryanne McGuckin,J. Sanford Schwartz,José J. Escarce.Indications for and Outcomes of Cholecystectomy: A Comparison of the Pre and Postlaparoscopic Eras[J].Annals of Surgery.1998(3)
  • 10Judy A. Shea,Michael J. Healey,Jesse A. Berlin,John R. Clarke,Peter F. Malet,Rudolf N. Staroscik,J. Sanford Schwartz,Sankey V. Williams.Mortality and Complications Associated with Laparoscopic Cholecystectomy: A Meta-Analysis[J].Annals of Surgery.1996(5)

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部